February 19, 2017 2:27 PM ET

Biotechnology

Company Overview of Nerium Biotechnology, Inc.

Company Overview

Nerium Biotechnology, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of Nerium oleander-based products for the treatment of various forms of proliferative diseases and viral infections in the United States and Honduras. It is also involved in the research, development, and manufacture of a skincare/cosmetic line of products based on the patented Nerium-aloe extract. The company develops Anvirzel, an oleander based cancer drug; Nerium Immune to provide immune support; and Nerium Viral for use as an adjuvant therapy in the treatment of hepatitis C and other antiviral support. It also offers NeriumAD night cream, which is a cosmetic product for u...

220 Bay Street

Unit 500

Toronto, ON M5J 2W4

Canada

Founded in 2006

Key Executives for Nerium Biotechnology, Inc.

Chairman, Chief Executive Officer and President
Age: 65
Chief Financial Officer
Executive Vice President, Secretary and Treasurer
Age: 59
Compensation as of Fiscal Year 2016.

Nerium Biotechnology, Inc. Key Developments

Nerium Biotechnology, Inc. Announces Board Changes

Nerium Biotechnology, Inc. announced the appointment of Kerry Mitchell to its board of directors. Ms. Mitchell has extensive experience as a media executive, with a strong record of building and transforming multi-platform media brands that include some of the most iconic names in Canadian publishing. Ms. Mitchell has been appointed to replace John Christopher Wansbrough, who has resigned from Nerium’s board of directors.

Nerium Biotechnology, Inc., Annual General Meeting, Jun 23, 2016

Nerium Biotechnology, Inc., Annual General Meeting, Jun 23, 2016, at 10:00 US Eastern Standard Time. Location: law offices of Blake, Cassels & Graydon LLP 199 Bay Street, Suite 4000 Toronto Ontario Canada Agenda: To receive the audited consolidated financial statements of the company for the year ended December 31, 2015, together with the report of the auditors thereon; to elect directors of the company for the ensuing year; to re-appoint auditors and to authorize the directors to fix their remuneration; and to transact such further or other business as may properly come before the Meeting or any adjournment or adjournments thereof.

Nerium Biotechnology, Inc, Annual General Meeting, Jun 26, 2015

Nerium Biotechnology, Inc, Annual General Meeting, Jun 26, 2015., at 10:00 US Eastern Standard Time. Location: Law offices of Stikeman Keeley Spiegel Pasternack LLP. Agenda: To receive the audited consolidated financial statements of the Company for the year ended December 31, 2014, together with the report of the auditors thereon; to elect directors of the Company for the ensuing year; to re-appoint auditors and to authorize the directors to fix their remuneration; to consider and, if thought advisable, pass an ordinary resolution, with or without variation, to adopt a Shareholders Rights Plan; and to transact such further or other business as may properly come before the Meeting or any adjournment or adjournments thereof.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nerium Biotechnology, Inc., please visit www.neriumbiotech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.